We are live on ! Find out more
OCEAW

Ocean Biomediacal, Inc. Warrants

Delisted

OCEAW was delisted on the 23rd of April, 2025.

20 hedge funds and large institutions have $1.79M invested in Ocean Biomediacal, Inc. Warrants in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

5% more funds holding

Funds holding: 1920 (+1)

34% less capital invested

Capital invested by funds: $2.7M → $1.79M (-$915K)

Holders
20
Holders Change
+1
Holders Change %
+5.26%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
2
Closed
Calls
$8K
Puts
Net Calls
+$8K
Net Calls Change
-$3K

OCEAW Hedge Fund Activity: Q3 2023 in Review

20 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomediacal, Inc. Warrants (OCEAW) for Q3 2023, worth a combined $1.79M — down 34% from $2.7M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new OCEAW positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Walleye Capital, adding an estimated $4.51K. The largest seller was Wolverine Asset Management, cutting an estimated $53.

  • 20 institutional investors held Ocean Biomediacal, Inc. Warrants (OCEAW) as of Q3 2023, up from 19 in Q2 2023.
  • Funds reported $1.79M of Ocean Biomediacal, Inc. Warrants stock for Q3 2023, down 34% quarter-over-quarter.
  • 1 fund opened new Ocean Biomediacal, Inc. Warrants positions in Q3 2023 and 0 closed out, a net change of +1 holder.
  • The largest Ocean Biomediacal, Inc. Warrants buyer in Q3 2023 was Walleye Capital, an estimated $4.51K added.
  • The largest Ocean Biomediacal, Inc. Warrants seller in Q3 2023 was Wolverine Asset Management, an estimated $53 sold.

Based on aggregated 13F filings for Q3 2023.